Euromedis Groupe SA (ALEMG) - Total Assets

Latest as of December 2025: €39.49 Million EUR ≈ $46.17 Million USD

Based on the latest financial reports, Euromedis Groupe SA (ALEMG) holds total assets worth €39.49 Million EUR (≈ $46.17 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check ALEMG total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Euromedis Groupe SA - Total Assets Trend (2009–2025)

This chart illustrates how Euromedis Groupe SA's total assets have evolved over time, based on quarterly financial data. Explore Euromedis Groupe SA long-term investment allocation to see how much of total assets are deployed in long-term investments.

Euromedis Groupe SA - Asset Composition Analysis

Current Asset Composition (December 2025)

Euromedis Groupe SA's total assets of €39.49 Million consist of 96.8% current assets and 3.2% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 42.2%
Accounts Receivable €10.77 Million 27.3%
Inventory €10.78 Million 27.3%
Property, Plant & Equipment €0.00 0.0%
Intangible Assets €297.46K 0.8%
Goodwill €0.00 0.0%

Asset Composition Trend (2009–2025)

This chart illustrates how Euromedis Groupe SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Euromedis Groupe SA (ALEMG) market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Euromedis Groupe SA's current assets represent 96.8% of total assets in 2025, an increase from 65.1% in 2009.
  • Cash Position: Cash and equivalents constituted 42.2% of total assets in 2025, up from 3.0% in 2009.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 23.0% in 2009.
  • Asset Diversification: The largest asset category is inventory at 27.3% of total assets.

Euromedis Groupe SA Competitors by Total Assets

Key competitors of Euromedis Groupe SA based on total assets are shown below.

Company Country Total Assets
Excelsior Medical Co Ltd
TW:4104
Taiwan NT$18.80 Billion
Sigma Healthcare Ltd
AU:SIG
Australia AU$8.74 Billion
Ebos Group Ltd
AU:EBO
Australia AU$8.80 Billion
Paragon Care Ltd
AU:PGC
Australia AU$1.31 Billion
Mayne Pharma Group Ltd
AU:MYX
Australia AU$1.01 Billion
Cyclopharm Ltd
AU:CYC
Australia AU$46.10 Million
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
China CN¥235.37 Billion
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
China CN¥89.76 Billion

Euromedis Groupe SA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.47 3.53 2.45
Quick Ratio 1.78 2.41 1.69
Cash Ratio 0.00 0.00 0.00
Working Capital €22.78 Million €26.99 Million €49.24 Million

Euromedis Groupe SA - Advanced Valuation Insights

This section examines the relationship between Euromedis Groupe SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.89
Latest Market Cap to Assets Ratio 0.36
Asset Growth Rate (YoY) 1.8%
Total Assets €39.49 Million
Market Capitalization $14.11 Million USD

Valuation Analysis

Below Book Valuation: The market values Euromedis Groupe SA's assets below their book value (0.36x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Euromedis Groupe SA's assets grew by 1.8% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Euromedis Groupe SA (2009–2025)

The table below shows the annual total assets of Euromedis Groupe SA from 2009 to 2025.

Year Total Assets Change
2025-12-31 €39.49 Million
≈ $46.17 Million
+1.81%
2024-12-31 €38.79 Million
≈ $45.35 Million
-16.15%
2023-12-31 €46.26 Million
≈ $54.08 Million
-22.73%
2022-12-31 €59.87 Million
≈ $69.99 Million
-17.68%
2021-12-31 €72.72 Million
≈ $85.02 Million
-21.48%
2020-12-31 €92.61 Million
≈ $108.28 Million
+53.95%
2019-12-31 €60.16 Million
≈ $70.33 Million
+19.47%
2018-12-31 €50.36 Million
≈ $58.87 Million
-12.03%
2017-12-31 €57.24 Million
≈ $66.92 Million
+0.86%
2016-12-31 €56.75 Million
≈ $66.35 Million
+0.36%
2015-12-31 €56.55 Million
≈ $66.11 Million
+1.99%
2014-12-31 €55.44 Million
≈ $64.82 Million
+0.97%
2013-12-31 €54.91 Million
≈ $64.20 Million
-0.44%
2012-12-31 €55.15 Million
≈ $64.48 Million
-1.80%
2011-12-31 €56.16 Million
≈ $65.66 Million
+1.17%
2010-12-31 €55.51 Million
≈ $64.90 Million
+3.38%
2009-12-31 €53.69 Million
≈ $62.77 Million
--

About Euromedis Groupe SA

PA:ALEMG France Medical Distribution
Market Cap
$17.03 Million
€14.57 Million EUR
Market Cap Rank
#26165 Global
#437 in France
Share Price
€5.10
Change (1 day)
+4.08%
52-Week Range
€3.83 - €5.75
All Time High
€24.90
About

Laboratoires Euromedis Société anonyme manufactures, imports, and distributes single-use medical devices for public and private healthcare facilities. It provides gloves; clothing and protection; draping and fields; compresses, cotton, dressings, strips and nets, and skincare products; sets and instrumentation; needles, syringes, microperfusionists; infusion and transfusion services, catheters, a… Read more